Your browser doesn't support javascript.
loading
Practical considerations for navigating the regulatory landscape of non-clinical studies for clinical translation of radiopharmaceuticals.
Korde, Aruna; Mikolajczak, Renata; Kolenc, Petra; Bouziotis, Penelope; Westin, Hadis; Lauritzen, Mette; Koole, Michel; Herth, Matthias Manfred; Bardiès, Manuel; Martins, Andre F; Paulo, Antonio; Lyashchenko, Serge K; Todde, Sergio; Nag, Sangram; Lamprou, Efthimis; Abrunhosa, Antero; Giammarile, Francesco; Decristoforo, Clemens.
Afiliação
  • Korde A; Department of Nuclear Sciences and Applications, International Atomic Energy Agency (IAEA), Vienna International Centre, PO Box 100, 1400, Vienna, Austria.
  • Mikolajczak R; Radioisotope Centre POLATOM, National Centre for Nuclear Research, Andrzej Soltan 7, 05-400, Otwock, Poland.
  • Kolenc P; Department of Nuclear Medicine, University Medical Centre Ljubljana, 1000, Ljubljana, Slovenia.
  • Bouziotis P; Faculty of Pharmacy, University of Ljubljana, 1000, Ljubljana, Slovenia.
  • Westin H; National Centre for Scientific Research "Demokritos", Institute of Nuclear & Radiological Sciences and Technology, Energy & Safety, 15341, Athens, Greece.
  • Lauritzen M; Department of Immunology, Genetics and Pathology, Ridgeview Instruments AB, Uppsala Universitet, Dag Hammarskjölds Väg 36A, 752 37, Uppsala, Sweden.
  • Koole M; Bruker BioSpin MRI GmbH, Rudolf-Plank-Str. 23, 76275, Ettlingen, Germany.
  • Herth MM; Nuclear Medicine and Molecular Imaging, Katholieke Universiteit Leuven, 3000, Louvain, Belgium.
  • Bardiès M; Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Jagtvej 160, 2100, Copenhagen, Denmark.
  • Martins AF; Department of Clinical Physiology, Nuclear Medicine and PET, Copenhagen University Hospital, Blegdamsvej 3, 2200, Copenhagen, Denmark.
  • Paulo A; Institut de Recherche en Cancérologie de Montpellier (IRCM), INSERM U1194, Institut Régional du Cancer de Montpellier (ICM), Université de Montpellier, 34298, Montpellier, France.
  • Lyashchenko SK; Department of Preclinical Imaging and Radiopharmacy, Werner Siemens Imaging Center, Eberhard Karls University Tübingen, Röntgenweg 13/1, 72076, Tübingen, Germany.
  • Todde S; Cluster of Excellence iFIT (EXC 2180) "Image-Guided and Functionally Instructed Tumor Therapies", University of Tübingen, Tübingen, Germany.
  • Nag S; Centro de Ciências E Tecnologias Nucleares, Instituto Superior Técnico, Universidade de Lisboa, Bobadela Lrs, Campus Tecnológico e Nuclear, Estrada Nacional 10, Km 139.7, 2695-066, Lisbon, Portugal.
  • Lamprou E; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Abrunhosa A; Department of Medicine and Surgery, University of Milano-Bicocca, Tecnomed Foundation, Milan, Italy.
  • Giammarile F; Department of Clinical Neuroscience, Centre for Psychiatry Research, Karolinska Institutet and Stockholm County Council, 171 76, Stockholm, Sweden.
  • Decristoforo C; Bioemtech, Lefkippos Attica Technology Park-N.C.S.R Demokritos, Athens, Greece.
EJNMMI Radiopharm Chem ; 7(1): 18, 2022 Jul 19.
Article em En | MEDLINE | ID: mdl-35852679

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article